USA – FDA Analysis Of Pfizer COVID-19 Vaccine Finds It Effective And Safe

The Food and Drug Administration released a detailed analysis Tuesday morning of the COVID-19 vaccine from Pfizer and its partner BioNTech ahead of a Thursday meeting of a group of independent experts that will advise the agency on whether to grant the vaccine an emergency use authorization.

The agency’s analysis finds « no specific safety concerns identified that would preclude issuance of an EUA. » Serious reactions were rare. Side effects are common, however, with a majority of study volunteers experiencing reactions at the site of injection, headaches and fatigue…